{"id":"07176","slug":"advanced-closed-loop--07176","source":{"id":"07176","dataset":"techtransfer","title":"Advanced Closed-Loop Neurostimulation System with Real-Time Impedance Monitoring for Enhanced Electrode Longevity","description_":"<p>This neurostimulation technology introduces a sophisticated implantable stimulator system that utilizes real-time impedance measurement and adaptive charge-balanced, asymmetric biphasic pulses to enhance therapeutic efficacy, electrode longevity, and patient safety.</p><p><h2>Description</h2>The technology consists of a stimulator system featuring an implantable electrode and electronic circuitry that includes a current source and a control system. The system is designed to deliver current-controlled stimulation (CCS) using an asymmetric, biphasic pulse where the first phase (e.g., a square wave) is followed by a second phase with a gradually decaying amplitude. This decaying amplitude, often achieved via an exponential decay from a discharging capacitor, is dynamically adjusted based on real-time impedance measurements at the electrode-tissue interface.\r\n\r\nThe control system employs an algorithm based on an RC circuit model to determine precise parameters for the second phase, ensuring charge balance between the two phases. By utilizing a processor and memory system to analyze impedance data at multiple frequencies, the stimulator can maintain a charge discrepancy of less than 5%, effectively mitigating the irreversible electrochemical reactions that typically lead to electrode corrosion and tissue injury.</p><p><h2>Applications</h2>- Chronic pain management through targeted neurostimulation therapies.\r<br>- Implantable medical devices requiring safe, long-term neural stimulation with minimized electrode wear.\r<br>- Neuromodulation treatments for neurological disorders necessitating precise current delivery despite variable tissue impedance.\r<br>- Research applications involving controlled electrical stimulation of neural tissue with emphasis on electrode durability and safety.\r<br>- Design and development of advanced bioelectronic interfaces incorporating real-time impedance feedback and adaptive stimulation waveforms.</p><p><h2>Advantages</h2>- Precise Current Delivery: The use of current-controlled stimulation ensures that therapeutic currents remain consistent irrespective of changes in tissue impedance, thereby enhancing treatment reliability.\r<br>- Charge Balancing with Asymmetric Biphasic Pulses: By implementing a biphasic pulse where the second phase decays gradually, the system effectively neutralizes net charge, preventing electrode material degradation and mitigating risk of tissue damage.\r<br>- Impedance Monitoring and Adaptive Control: Continuous measurement of electrode-tissue impedance allows dynamic adjustment of stimulation parameters, optimizing both efficacy and safety.\r<br>- Advanced Circuitry Integration: The inclusion of processors, memory, and DACs facilitates complex algorithms for charge calculation and waveform generation, enabling sophisticated and customizable stimulation protocols.\r<br>- Demonstrated Electrode Longevity: Experimental validation underscores the system’s capacity to maintain electrode integrity under chronic operation, promising longer implant service life.\r<br>- User Interface and Programmability: Provides medical practitioners the ability to monitor, modify, and tailor stimulation parameters to patient-specific needs efficiently.</p><p><h2>Invention Readiness</h2>The neurostimulation system has progressed through design, fabrication, and in vitro testing stages, establishing foundational proof-of-concept and performance benchmarks. Experimental data affirm the system's ability to control charge delivery precisely and adapt to variable impedance environments, indicating strong potential for clinical translation. Further studies involving comprehensive in vivo validation and long-term biocompatibility assessments are recommended to support regulatory approval and facilitate clinical implementation.</p><p><h2>IP Status</h2>Patent Pending</p><p></p>","tags":["Platform Technology","Algorithm"],"file_number":"07176","collections":[],"meta_description":"Real-time impedance-driven closed-loop neurostimulation with asymmetric biphasic pulses enhances electrode longevity and safety.","image_url":"","apriori_judge_output":"{\"scores\":{\"novelty\":4.0,\"potential_impact\":4.0,\"readiness\":4.0,\"scalability\":3.0,\"timeliness\":3.0},\"weighted_score\":3.95,\"risks\":[\"TRL4 with in vivo validation pending introduces regulatory and translational risk\",\"Complex implantable hardware may face Cytotoxicity and long-term biocompatibility challenges\",\"Impedance analytics and RC-model algorithm may add power/thermal constraints\",\"Manufacturing scalability and regulatory pathway for chronic implants could slow adoption\"],\"one_sentence_take\":\"Innovative real-time impedance-driven closed-loop stimulation shows strong novelty and potential but faces translational hurdles and regulatory complexity before clinical-ready, with moderate scalability constraints.\"}","lead_inventor_name":"Kangni Liu","lead_inventor_dept":"Electrical and Computer Engineering","technology_type":"Medical Device","technology_subtype":"Implantable Medical Device","therapeutic_areas":["Neuroscience"],"therapeutic_indications":["Parkinson's Disease","Pain"],"custom_tags":[],"all_tech_innovators":["Guangzong Chen","Rajkumar Chinnakonda Kubendran","Xinyan Cui","Kangni Liu","Kevin M. Woeppel"],"date_submitted":"2025-05-06","technology_readiness_level":"4. Prototype testing and refinement"},"highlight":{},"matched_queries":null,"score":0.0}